The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...

Ritlecitinib and baricitinib have similar rates of hair regrowth at 24 weeks of treatment in patients with severe alopecia areata.

researchers applied machine learning algorithms to a biomedical knowledge graph to uncover the potential of baricitinib. This ...

The anti-inflammatory baricitinib is normally used to treat rheumatoid arthritis. Trials suggest it can cut death risk by about a fifth in patients needing hospital care for severe Covid.

Baricitinib is an effective treatment option for children and adolescents with atopic dermatitis, with no new safety signals identified.